Literature DB >> 16214291

Differential expression of selectins by mouse brain capillary endothelial cells in vitro in response to distinct inflammatory stimuli.

Caroline Coisne1, Christelle Faveeuw, Yannick Delplace, Lucie Dehouck, Florence Miller, Roméo Cecchelli, Bénédicte Dehouck.   

Abstract

Increased lymphocyte trafficking across blood-brain barrier (BBB) is a prominent and early event in inflammatory and immune-mediated CNS diseases. The adhesion molecules that control the entry of leukocytes into the brain have not been fully elucidated. Although the role of ICAM-1 and VCAM-1 has been well documented, the expression and role of selectins is still a matter of controversy. In a mouse syngenic in vitro BBB model, highly relevant for examining immunological events, mouse brain capillary endothelial cells (MBCECs) do not express selectins. Treatment of MBCECs with LPS, induced E- and P-selectin expression, whereas TNF-alpha or IFN-gamma treatments did not. Finally, P-selectin but not E-selectin expression was induced in IL-1beta treated MBCECs. Thus, our study suggests that diverse inflammatory stimuli could differentially regulate selectin expression at the BBB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16214291     DOI: 10.1016/j.neulet.2005.09.028

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation.

Authors:  Oliver Steiner; Caroline Coisne; Britta Engelhardt; Ruth Lyck
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-07       Impact factor: 6.200

2.  Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain.

Authors:  Meiqing Shi; Shu Shun Li; Chunfu Zheng; Gareth J Jones; Kwang Sik Kim; Hong Zhou; Paul Kubes; Christopher H Mody
Journal:  J Clin Invest       Date:  2010-04-26       Impact factor: 14.808

3.  Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.

Authors:  Karl V Clemons; Julie A Schwartz; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

4.  Intracellular transport of Toxoplasma gondii through the blood-brain barrier.

Authors:  Sabrina M Lachenmaier; Mária A Deli; Markus Meissner; Oliver Liesenfeld
Journal:  J Neuroimmunol       Date:  2010-11-23       Impact factor: 3.478

Review 5.  Meningeal Lymphatics: From Anatomy to Central Nervous System Immune Surveillance.

Authors:  Zachary Papadopoulos; Jasmin Herz; Jonathan Kipnis
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

6.  Astroglia in Sepsis Associated Encephalopathy.

Authors:  Tatyana Shulyatnikova; Alexei Verkhratsky
Journal:  Neurochem Res       Date:  2019-02-18       Impact factor: 3.996

7.  Amyloid-β peptide on sialyl-Lewis(X)-selectin-mediated membrane tether mechanics at the cerebral endothelial cell surface.

Authors:  Sholpan Askarova; Zhe Sun; Grace Y Sun; Gerald A Meininger; James C-M Lee
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

8.  The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctions.

Authors:  Esther Steiner; Gaby U Enzmann; Ruth Lyck; Shuo Lin; Markus A Rüegg; Stephan Kröger; Britta Engelhardt
Journal:  Cell Tissue Res       Date:  2014-08-09       Impact factor: 5.249

Review 9.  To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis.

Authors:  Maxime De Laere; Zwi N Berneman; Nathalie Cools
Journal:  J Neuropathol Exp Neurol       Date:  2018-03-01       Impact factor: 3.685

Review 10.  In vitro modeling of blood-brain barrier and interface functions in neuroimmune communication.

Authors:  Michelle A Erickson; Miranda L Wilson; William A Banks
Journal:  Fluids Barriers CNS       Date:  2020-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.